Search Results - "Cirrincione, C."

Corrosion inhibition of iron in acidic solution by a green formulation derived from Nigella sativa L by Chellouli, M., Chebabe, D., Dermaj, A., Erramli, H., Bettach, N., Hajjaji, N., Casaletto, M.P., Cirrincione, C., Privitera, A., Srhiri, A.

“…In this work the corrosion inhibition of iron in acidic solution by a formulation based on the oil extracted from the seeds of Nigella Sativa L. (labeled as…”
Get full text

Paclitaxel efficacy and toxicity in older women with metastatic breast cancer: combined analysis of CALGB 9342 and 9840 by Lichtman, S.M., Hurria, A., Cirrincione, C.T., Seidman, A.D., Winer, E., Hudis, C., Cohen, H.J., Muss, H.B.

“…Two Cancer and Leukemia Group B (CALGB) studies were utilized to determine the efficacy and tolerability of paclitaxel (Taxol) in older patients with…”
Get full text

Evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for hormone receptor–positive metastatic breast cancer: a pooled analysis from the LEA (GEICAM/2006-11_GBG51) and CALGB 40503 (Alliance) trials by Martín, M., Loibl, S., Hyslop, T., De la Haba-Rodríguez, J., Aktas, B., Cirrincione, C.T., Mehta, K., Barry, W.T., Morales, S., Carey, L.A., Garcia-Saenz, J.A., Partridge, A., Martinez-Jañez, N., Hahn, O., Winer, E., Guerrero-Zotano, A., Hudis, C., Casas, M., Rodriguez-Martin, C., Furlanetto, J., Carrasco, E., Dickler, M.N.

“…Randomised trials comparing the efficacy of standard endocrine therapy (ET) versus experimental ET + bevacizumab (Bev) in 1st line hormone…”
Get full text

Predictors of duloxetine response in patients with oxaliplatin‐induced painful chemotherapy‐induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial – CALGB/alliance 170601 by Smith, E.M.L., Pang, H., Ye, C., Cirrincione, C., Fleishman, S., Paskett, E.D., Ahles, T., Bressler, L.R., Le‐Lindqwister, N., Fadul, C.E., Loprinzi, C., Shapiro, C.L.

“…Duloxetine is an effective treatment for oxaliplatin‐induced painful chemotherapy‐induced peripheral neuropathy (CIPN). However, predictors of duloxetine…”
Get full text

c-erbB-2 Expression and Response to Adjuvant Therapy in Women with Node-Positive Early Breast Cancer by Muss, Hyman B, Thor, Ann D, Berry, Donald A, Kute, Timothy, Liu, Edison T, Koerner, Frederick, Cirrincione, Constance T, Budman, Daniel R, Wood, William C, Barcos, Maurice, Henderson, I. Craig

“…Several molecular markers have been associated with a poor prognosis in patients with breast cancer, and it is widely assumed that the presence of these…”
Get full text

413 Relationship Between Body Mass Index (BMI) and Outcomes in Node-positive Breast Cancer Patients Receiving Chemotherapy–Results From CALGB/Intergroup 9741 by Ligibel, J, Cirrincione, C, Citron, M, Ingle, J, Gradishar, W, Martino, S, Hudis, C, Winer, E, Berry, D

Get full text

Lamina Propria Dendritic Cells Express Activation Markers and Contact Lymphocytes in Chronic Periodontitis by Cirrincione, Claudio, Pimpinelli, Nicola, Orlando, Lorenzo, Romagnoli, Paolo

“…Background: Dendritic cells are characterized by shape, structure, and membrane molecule expression; they contact T lymphocytes to present antigens and…”
Get full text

Fifteen-year median follow-up results after neoadjuvant doxorubicin, followed by mastectomy, followed by adjuvant cyclophosphamide, methotrexate, and fluorouracil (CMF) followed by radiation for stage III breast cancer: a phase II trial (CALGB 8944) by Kimmick, G. G., Cirrincione, C., Duggan, D. B., Bhalla, K., Robert, N., Berry, D., Norton, L., Lemke, S., Henderson, I. C., Hudis, C., Winer, E.

“…Purpose To describe long-term results of a multimodality strategy for stage III breast cancer utilizing neoadjuvant doxorubicin followed by mastectomy, CMF,…”
Get full text

Dose and Dose Intensity as Determinants of Outcome in the Adjuvant Treatment of Breast Cancer by Budman, Daniel R., Berry, Donald A., Cirrincione, Constance T., Henderson, I. Craig, Wood, William C., Weiss, Raymond B., Ferree, Carolyn R., Muss, Hyman B., Green, Mark R., Norton, Larry, Frei, Emil

“…Background: Both total dose and dose intensity of adjuvant chemotherapy are postulated to be important variables in the outcome for patients with operable…”
Get full text

The effect of renal function on outcomes in the adjuvant treatment of older women with breast cancer by Lichtman, S.M, Cirrincione, C, Hurria, A, Jatoi, A, Cohen, H.J, Muss, H.B

Get full text

Phase III Study of Cyclophosphamide, Doxorubicin, and Fluorouracil (CAF) Plus Leucovorin Versus CAF for Metastatic Breast Cancer: Cancer and Leukemia Group B 9140 by PARNES, H. L, CIRRINCIONE, C, SZATROWSKI, T. P, HENDERSON, I. C, NORTON, L, AISNER, J, BERRY, D. A, ALLEN, S. L, ABRAMS, J, CHUANG, E, COOPER, M. R, PERRY, M. C, DUGGAN, D. B

“…To determine whether biochemical modulation with LV (leucovorin) enhances the efficacy of CAF (cyclophosphamide, doxorubicin, and fluorouracil) against…”
Get full text

Controlling delayed vomiting: double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin by Kris, M G, Gralla, R J, Tyson, L B, Clark, R A, Cirrincione, C, Groshen, S

“…The majority of patients receiving cisplatin at a dose of 120 mg/m2 experience delayed nausea and vomiting occurring between 24 and 120 hours after…”
Get more information

Circulating HER-2/erbB-2/c-neu (HER-2) extracellular domain as a prognostic factor in patients with metastatic breast cancer : Cancer and leukemia Group B study 8662 by HAYES, Daniel F, YAMAUCHI, Hideko, NORTON, Larry, HENDERSON, I. Craig, BROADWATER, Gloria, CIRRINCIONE, Constance T, RODRIGUE, Stephen P, BERRY, Donald A, YOUNGER, Jerry, PANASCI, Lawrence L, MILLARD, Frederick, DUGGAN, David B

“…The HER-2/erbB-2/c-neu (HER-2) proto-oncogene is a M(r) 185,000 transmembrane tyrosine kinase that is amplified and/or overexpressed by 20-40% of breast…”
Get full text

Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy: A Randomized Clinical Trial by Smith, Ellen M. Lavoie, Pang, Herbert, Cirrincione, Constance, Fleishman, Stewart, Paskett, Electra D, Ahles, Tim, Bressler, Linda R, Fadul, Camilo E, Knox, Chetaye, Le-Lindqwister, Nguyet, Gilman, Paul B, Shapiro, Charles L

“…IMPORTANCE There are no known effective treatments for painful chemotherapy-induced peripheral neuropathy. OBJECTIVE To determine the effect of duloxetine, 60…”
Get full text

Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37298 women with early breast cancer in 26 randomised trials by Boddington, C, Bradley, R, Braybrooke, J, Burrett, J, Clarke, M, Davies, C, Davies, L, Dodwell, D, Duane, F, Evans, V

Get full text

Primary CNS lymphoma: combined treatment with chemotherapy and radiotherapy by DE ANGELIS, L. M, YAHALOM, J, HEINEMANN, M.-H, CIRRINCIONE, C, THALER, H. T, KROL, G

“…Primary central nervous system lymphoma (PCNSL), an uncommon tumor, is occurring with increasing frequency. Conventional therapy with corticosteroids and…”
Get full text

Arm edema in conservatively managed breast cancer: obesity is a major predictive factor by Werner, R S, McCormick, B, Petrek, J, Cox, L, Cirrincione, C, Gray, J R, Yahalom, J

“…To identify risk factors in the development of arm edema (AE) after conservative management of breast cancer, the authors prospectively measured differences in…”
Get more information

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials by Davies, C, Godwin, J, Gray, R, Clarke, M, Cutter, D, Darby, S, McGale, P, Pan, H C, Taylor, C, Wang, Y C, Dowsett, M, Ingle, J, Peto, R

“…Summary Background As trials of 5 years of tamoxifen in early breast cancer mature, the relevance of hormone receptor measurements (and other patient…”
Get full text

Secondary myelodysplasia and acute leukemia in breast cancer patients after autologous bone marrow transplant by Laughlin, M J, McGaughey, D S, Crews, J R, Chao, N J, Rizzieri, D, Ross, M, Gockerman, J, Cirrincione, C, Berry, D, Mills, L, Defusco, P, LeGrand, S, Peters, W P, Vredenburgh, J J

“…To determine the incidence of myelodysplasia (MDS) and/or acute leukemia (AL) in breast cancer patients after high-dose chemotherapy (HDC) with a single…”
Get more information

Cryptococcal Meningitis: Outcome in Patients with AIDS and Patients with Neoplastic Disease by White, Mary, Cirrincione, Constance, Blevins, Anne, Armstrong, Donald

“…A retrospective analysis of 41 patients with cryptococcal meningitis and AIDS or neoplastic disease was done. Patients with AIDS were younger and predominantly…”
Get full text